Skip to content

Clinical trials

Completed Observational Inflammatory Bowel Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Observational Status: Completed Clear all

273 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20032
20045
20052
20064
20075
20085
20097
20106
201112
201213
201314
201419
201521
201618
201722
201815
201915
202021
202118
202215
202314
202410
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed273

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda18
Central Hospital, Nancy, France5
Second Affiliated Hospital, Zhejiang University, School of Medicine5
Icahn School of Medicine at Mount Sinai4
Sixth Affiliated Hospital, Sun Yat-sen University4
University Hospital, Lille4
Assistance Publique - Hôpitaux de Paris3
Assiut University3
Centre Hospitalier Universitaire de Saint Etienne3
Connecticut Children's Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases273
Crohn Disease110
Colitis, Ulcerative106
Colorectal Neoplasms11
Irritable Bowel Syndrome11
Arthritis, Rheumatoid8
Arthritis, Psoriatic6
Diabetes Mellitus5
Gastrointestinal Diseases5
Psoriasis5

Trials

Showing 1 to 25 of 273. Each trial links to its page on Pharma Observatory.

173 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.